Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 6 515-518, Copyright © 1994 by American Association for Cancer Research

ARTICLES

Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer

S Kato, PG Shields, NE Caporaso, H Sugimura, GE Trivers, MA Tucker, BF Trump, A Weston and CC Harris
Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892.

Human cancer risk assessment using molecular genetic techniques is a rapidly emerging field. Many studies suggest that both inherited and acquired genetic predispositions play an important role in carcinogenesis. Cytochrome P450 (CYP) 2E1 is involved in the metabolic activation of N-nitrosamines and other low molecular weight compounds. A recently described genetic polymorphism of CYP2E1 [DraI restriction fragment length polymorphism (RFLP)] has been associated with an increased risk of lung cancer in Japanese. We have assessed the allelic frequency of three RFLPs (PstI, RsaI, and DraI) in African-Americans (n = 109), Caucasian Americans (n = 153), and octogenarian Japanese (n = 42), and also in a United States case-control study of lung cancer (histologically confirmed lung cancer, n = 58; controls, n = 56; total, n = 114). The relationship of the CYP2E1 DraI polymorphism to other CYP2E1 polymorphisms (PstI and RsaI RFLP) was examined. The allelic frequency of the DraI C minor allele for all subjects was 0.09 in Caucasians, 0.09 in African-Americans, and 0.31 in Japanese. In the case-control study of lung cancer, no association of the CYP2E1 DraI genotype with lung cancer was found (odds ratio, 1.57; 95% confidence interval, 0.59-4.18). Comparison after discordant CYP2E1 genotypes suggests the presence of different haplotypes in Americans and Japanese. These results indicate that the CYP2E1 DraI RFLP is probably not a cancer risk factor in United States Caucasian or African-Americans, although statistical power is limited given the low frequency of the CYP2E1 DraI C minor alleles.

This article has been cited by other articles:

				G E Goodman Lung cancer * 1: Prevention of lung cancer Thorax, November 1, 2002; 57(11): 994 - 999. [Abstract] [Full Text] [PDF]

				I. N. Nishimoto, T. Hanaoka, H. Sugimura, K. Nagura, M. Ihara, X.-J. Li, T. Arai, G. S. Hamada, L. P. Kowalski, and S. Tsugane Cytochrome P450 2E1 Polymorphism in Gastric Cancer in Brazil: Case-Control Studies of Japanese Brazilians and Non-Japanese Brazilians Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 675 - 680. [Abstract] [Full Text]

				H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text]

				L. L. Marchand, G. R. Wilkinson, and L. R. Wilkens Genetic and Dietary Predictors of CYP2E1 Activity: A Phenotyping Study in Hawaii Japanese Using Chlorzoxazone Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 495 - 500. [Abstract] [Full Text]